Omicron Variant: BioNTech CEO Ugur Sahin Says Vaccine for New COVID-19 Variant Should Be A 3-Dose Vaccine
The vaccine for new coronavirus variant, Omicron, should be a 3-dose vaccine, said CEO of BioNTech Ugur Sahin. Notably, BioNTech has developed a vaccine against COVID-19 in collaboration with Pfizer Inc.
Ugur Sahin, CEO of BioNTech, has said that with the available data on the new Coronavirus variant, it is very clear that there should a 3-dose vaccine for Omicron variant. The new COVID-19 variant, which was first detected in South Africa, has been called as 'Variant of Concern' by the WHO.
BioNTech CEO Ugur Sahin Says Vaccine for Omicron Variant Should Be A 3-Dose Vaccine:
JUST IN - BioNTech CEO: Potentially upcoming vaccine for the #Omicron variant "should be a 3-dose vaccine." pic.twitter.com/ounAm4Fd41
β Disclose.tv (@disclosetv) December 8, 2021
Vaccine For New COVID-19 Variant Should Be 3-Dose Vaccine, Says Sahin
"It is very clear the vaccine, for the Omicron variant, should be a 3-dose vaccine."- @BioNTech_Group CEO UΔur Εahin. pic.twitter.com/k5IenepW0s
β Anjalee Khemlani (@AnjKhem) December 8, 2021
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)
(The above story first appeared on LatestLY on Dec 08, 2021 08:45 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
